LSB Industries: Half the Beat Is Real, and Management Said So

A 55% EBITDA jump, a freshly quantified $100 million growth stack and a buyback hint — sitting on top of a 6.8% gross margin and a nitrogen squeeze nobody will size.

LXU · Earnings Call · 2026-10-29

The beat, and the half that's real

LSB Industries reported Q3 2026 adjusted EBITDA of $62 million against $40 million a year earlier — a 55% jump — and crossed more than $220 million of trailing-twelve-month adjusted EBITDA. On the headline, that is a cyclical hitting its stride: turnarounds behind it, US natural gas at roughly $3 per MMBtu while European producers pay $18–30, and a nitrogen market that has been short for six straight quarters. Then look at what was actually filed. The last 10-Q (period ending 24 July) shows gross margin of just 6.8%, down 8.5 percentage points year over year, an $8 million operating loss, and negative net income. Adjusted EBITDA and GAAP operating income are telling two very different stories about the same business — and on Wednesday, Cheryl Maguire effectively admitted why.

If you are looking at the quarter, and you take out kind of the inventory build, that is timing, it swings, and some of the precious metals, you are looking at probably half of it being sustainable going forward.
Cheryl Maguire, Chief Financial Officer · 2026-10-29

Half. Of a cost performance that carried the quarter. The giveaway sits at the very top of LSB's Q3 keyword set: precious metal recoveries, which surfaced as the company's single highest-momentum theme this quarter after being absent from the top ranks entirely a year ago. Precious metals are a routine part of the nitric acid process, but the timing and magnitude swing with metal prices — and gold has been elevated all year. That is not a moat; it is a call option that happened to expire in the money.

A promise, finally quantified

What is genuinely new in this report is that Mark Behrman stopped describing a pipeline and started putting numbers on a ledger. LSB now claims a path to approximately $100 million of cumulative incremental annualized EBITDA from initiatives launched since 2023 — $35 million of operational run-rate banked by year-end 2026 against a $55 million target, a further $15–20 million in 2027, plus the carbon capture project and the El Dorado expansion on top. The CCS project is the sharpest structural change. LSB took full ownership of the El Dorado sequestration asset from Lapis Carbon Solutions — a reversal of the partnership structure management described as recently as last October, when the Class VI permit was framed as the gating item on a jointly held venture. That permit now has its own keyword slot, and management is doing something unusual: publicly arguing with the EPA's own tracker. “Although the published EPA Underground Injection Control Class VI permit tracker reflects a potential operational date in the second half of 2027, based on our continued engagement with senior officials from the EPA's Region VI office, we believe an earlier operational date is possible.” — Mark Behrman, Chairman and Chief Executive Officer · 2026-10-29 That matters because the payoff is $25–30 million of annual earnings, net of operating costs, for twelve years of 45Q credits — roughly a quarter of the company's current EBITDA, from an asset already built and generating CO2 today. The ammonia expansion at El Dorado has moved from aspiration to spec sheet: 100,000 tons of capacity, $20–25 million of incremental EBITDA, $105–120 million net cost, FEED study and FID by Q2 2027, bolted onto the 2029 turnaround and funded from the cash balance. Contrast that with October 2025, when Behrman was explicit: “we're not prepared yet to talk about the expansion. I think we'll wait until we get through our engineering studies.” — Mark Behrman, Chairman and Chief Executive Officer · 2025-10-30 Twelve months later the numbers exist. That is real progress, and it is why the buyback signal landed differently than it would have a year ago. “We have a stock buyback authorization from the board, and I think that we'll try and be, even if it's small every quarter, be buying some stock back where we think it makes sense.” — Mark Behrman, Chairman and Chief Executive Officer · 2026-10-29 "Small" is doing a lot of work in that sentence, and it deserves scrutiny. With more than $200 million of cash, $27 million of quarterly free cash flow and net debt of about $222 million (net leverage ~1.1x), LSB is hoarding dry powder for acquisitions while letting a stock trade at 1.2x revenue. If the $100 million EBITDA promise is real, the board is being patient with the cheapest currency it owns.

The squeeze nobody will size

Analysts tried three times to get management to quantify the windfall from the ammonium nitrate shortage. Lucas Beaumont asked directly how much of the earnings base is "overearning" that rolls off, and Damien Renwick gave the most honest non-answer of the call: “Directionally the 10% is right. We would expect that to continue on all the way up until the supply issues are resolved sort of towards the end of first half next year.” — Damien Renwick, Chief Commercial Officer · 2026-10-29 That is a genuine new disclosure — an explicit end-date on the supply disruption premium, which previously had only been described as lasting "through the end of the year." It is also why Renwick's order book comment is the bullish counterweight: “we're probably 70% or so sold for the fourth quarter, so we do have some upside. And of course, we're significantly less sold for the first quarter.” — Damien Renwick, Chief Commercial Officer · 2026-10-29 If Tampa ammonia has moved up roughly $100 a ton since the $545 October settlement, the Q1 exposure is unhedged. The setup is laid out in ammonia production: European curtailments of 20–25%, or up to 2 million metric tons, against US gas at a structural discount. Watch the nitric acid leg too — MDI antidumping duties have kept domestic offtake strong, a small case study in the trade defense mechanism wave that steel and chemical producers globally were discussing this week. And watch the weather: a warm, dry fall has harvest running behind, which is the one variable that could turn a "strong" fall ammonia season into an ordinary one.

The loose ends

Two things management did not advertise. First, LSB was not among the eight projects selected for phase two of the USDA fertilizer funding programme — “it was a bit of a head-scratcher on some of the projects, to be honest.” — Mark Behrman, Chairman and Chief Executive Officer · 2026-10-29 The ~$30 million phase-one grant for debottlenecking is intact, but the bigger expansion cheque is not coming. Second, the Leidos trial began this week and will run three to four weeks; management declined to comment further, and given that trial-preparation costs were explicitly cited as an SG&A driver in the quarter, the resolution is a live swing factor for 2027. LSB's stock is up 3.9% over 90 days, 9% below its July high of $12.24, and still nearly 70% below its 2011 peak. The market is not paying for the $100 million story yet. Whether it should depends almost entirely on how much of the last quarter was nitrogen scarcity and how much was the annual run rate improvement management swears is permanent — and on that question, the CFO already told you the answer is roughly fifty-fifty.